Catalyst Pharmaceuticals (CPRX) Other Non Operating Income (2012 - 2026)

Catalyst Pharmaceuticals (CPRX) has 15 years of Other Non Operating Income data on file, last reported at $11.0 million in Q1 2026.

• Quarterly Other Non Operating Income rose 38.87% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 86.62% YoY) and the FY2025 annual result came in at $546000.0, down 97.42% from the prior year.
• Other Non Operating Income grew to $11.0 million in Q1 2026, from -$15.1 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $11.3 million in Q4 2024 to a low of -$15.1 million in Q4 2025.
• A 5-year average of $2.4 million and a median of $1.8 million in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 815.49% — and 2023, when it jumped 1732.26%.
• Tracing CPRX's Other Non Operating Income over 5 years: stood at -$508000.0 in 2022, then jumped by 1087.2% to $5.0 million in 2023, then jumped by 126.08% to $11.3 million in 2024, then sank by 233.5% to -$15.1 million in 2025, then surged by 172.65% to $11.0 million in 2026.
• The last three Other Non Operating Income figures came in at $11.0 million (Q1 2026), -$15.1 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.